| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| 1 | AN ACT concerning criminal law. | |||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
| 3 | represented in the General Assembly: | |||||||||||||||||||
| 4 | Section 5. The Illinois Controlled Substances Act is | |||||||||||||||||||
| 5 | amended by changing Section 201 as follows: | |||||||||||||||||||
| 6 | (720 ILCS 570/201) (from Ch. 56 1/2, par. 1201) | |||||||||||||||||||
| 7 | Sec. 201. (a) The Department shall carry out the | |||||||||||||||||||
| 8 | provisions of this Article. The Department or its successor | |||||||||||||||||||
| 9 | agency may, by administrative rule, add additional substances | |||||||||||||||||||
| 10 | to or delete or reschedule all controlled substances in the | |||||||||||||||||||
| 11 | Schedules of Sections 204, 206, 208, 210 and 212 of this Act. | |||||||||||||||||||
| 12 | In making a determination regarding the addition, deletion, or | |||||||||||||||||||
| 13 | rescheduling of a substance, the Department shall consider the | |||||||||||||||||||
| 14 | following: | |||||||||||||||||||
| 15 | (1) the actual or relative potential for misuse; | |||||||||||||||||||
| 16 | (2) the scientific evidence of its pharmacological | |||||||||||||||||||
| 17 | effect, if known; | |||||||||||||||||||
| 18 | (3) the state of current scientific knowledge | |||||||||||||||||||
| 19 | regarding the substance; | |||||||||||||||||||
| 20 | (4) the history and current pattern of misuse; | |||||||||||||||||||
| 21 | (5) the scope, duration, and significance of misuse; | |||||||||||||||||||
| 22 | (6) the risk to the public health; | |||||||||||||||||||
| 23 | (7) the potential of the substance to produce | |||||||||||||||||||
| |||||||
| |||||||
| 1 | psychological or physiological dependence or a substance | ||||||
| 2 | use disorder; | ||||||
| 3 | (8) whether the substance is an immediate precursor of | ||||||
| 4 | a substance already controlled under this Article; | ||||||
| 5 | (9) the immediate harmful effect in terms of | ||||||
| 6 | potentially fatal dosage; and | ||||||
| 7 | (10) the long-range effects in terms of permanent | ||||||
| 8 | health impairment. | ||||||
| 9 | (b) (Blank). | ||||||
| 10 | (c) (Blank). | ||||||
| 11 | (d) If any substance is scheduled, rescheduled, or deleted | ||||||
| 12 | as a controlled substance under Federal law and notice thereof | ||||||
| 13 | is given to the Department, the Department shall similarly | ||||||
| 14 | control the substance under this Act after the expiration of | ||||||
| 15 | 30 days from publication in the Federal Register of a final | ||||||
| 16 | order scheduling a substance as a controlled substance or | ||||||
| 17 | rescheduling or deleting a substance, unless within that 30 | ||||||
| 18 | day period the Department objects, or a party adversely | ||||||
| 19 | affected files with the Department substantial written | ||||||
| 20 | objections objecting to inclusion, rescheduling, or deletion. | ||||||
| 21 | In that case, the Department shall publish the reasons for | ||||||
| 22 | objection or the substantial written objections and afford all | ||||||
| 23 | interested parties an opportunity to be heard. At the | ||||||
| 24 | conclusion of the hearing, the Department shall publish its | ||||||
| 25 | decision, by means of a rule, which shall be final unless | ||||||
| 26 | altered by statute. Upon publication of objections by the | ||||||
| |||||||
| |||||||
| 1 | Department, similar control under this Act whether by | ||||||
| 2 | inclusion, rescheduling or deletion is stayed until the | ||||||
| 3 | Department publishes its ruling. | ||||||
| 4 | (d-1) If any substance, scheduled as a Schedule I | ||||||
| 5 | controlled substance by the Administration, is rescheduled for | ||||||
| 6 | the purpose of treating mental health disorders, including, | ||||||
| 7 | but not limited to, anxiety, depression, and post traumatic | ||||||
| 8 | stress disorder, the Department shall reschedule the substance | ||||||
| 9 | accordingly within 30 days from the publication in the Federal | ||||||
| 10 | Register of the final order rescheduling the substance. | ||||||
| 11 | (e) (Blank). | ||||||
| 12 | (f) (Blank). | ||||||
| 13 | (g) Authority to control under this Section does not | ||||||
| 14 | extend to distilled spirits, wine, malt beverages, or tobacco | ||||||
| 15 | as those terms are defined or used in the Liquor Control Act of | ||||||
| 16 | 1934 and the Tobacco Products Tax Act of 1995. | ||||||
| 17 | (h) Persons registered with the Drug Enforcement | ||||||
| 18 | Administration to manufacture or distribute controlled | ||||||
| 19 | substances shall maintain adequate security and provide | ||||||
| 20 | effective controls and procedures to guard against theft and | ||||||
| 21 | diversion, but shall not otherwise be required to meet the | ||||||
| 22 | physical security control requirements (such as cage or vault) | ||||||
| 23 | for Schedule V controlled substances containing | ||||||
| 24 | pseudoephedrine or Schedule II controlled substances | ||||||
| 25 | containing dextromethorphan. | ||||||
| 26 | (Source: P.A. 103-881, eff. 1-1-25.) | ||||||